NOVEL DRUGS AND DEVICES TO LOWER INTRAOCULAR PRESSURE MARKET ANALYSIS

Novel Drugs and Devices to Lower Intraocular Pressure Market, by Treatment Type (Drug (Rhopressa, Roclatan, Xelpros, Vyzulta and Others) and Device (Implant, Therapeutic Ultrasound and Others), by Distribution Channel (Hospitals & Clinics, Retail Channel and Online Channels), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Nov 2024
Code : CMI2670
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global Novel Drugs and Devices to Lower Intraocular Pressure Market Key Players

Some of the major players operating in the global novel drugs and devices to lower intraocular pressure market include, Mati Therapeutics Inc, BioLight Lifesciences Ltd., IOPtima Ltd., Eye Sonix, Bausch & Lomb Inc., Sun Pharmaceutical Industries Ltd., Allergan, Alcon Inc., Glaukos Corporation, and Pfizer Inc.